BioTech Pharma Summit
29-31 March 2017 | Porto,Portugal
KEY PRACTICAL LEARNING POINTS OF THE SUMMIT:
▶ The latest trends of the Biosimilars & Biologics
▶ Successful Commercialization of Biosimilars in the USA/Canada/Europe/India
▶ Innovative products and technologies in the global biologics market
▶ Challenges and opportunities in development of Biosimilars & Biologics
▶ Industry Partnerships: Key Success Factor to win in Biosimilar Space
▶ Regulatory Advice on Designing Biosimilar Trials
▶ Strategies for accelerating Biosimilars development and approval
▶ Biosimilars in emerging markets – regulatory and commercial considerations
▶ Strategies and competing products for a successful commercializationFeatured
BENEFITS OF ATTENDING
• Hear latest regulatory updates for smooth and speedy approval
• Learn successful biosimilar case studies to reshape your business model
• Dissect regional market growth opportunities – where should you go next ?
• Network with like-minded senior experts and engage in interactive debatesGroup
Featured Speakers
CommiteeProgram Chair
Program Commitee
EXPERTS FROM AROUND THE WORLD IN ONE PLACE
EPM Group is proud to present The BioTech Pharma Summit 2017, taking place in 29-31 of March 2017 in Porto, Portugal.
Over 200 delegates working in biosimilars and biologics, proteins, antibodies and peptides, representing global pharmaceuti-cal organisations, leading biotech companies and internationally renowned academic institutions will be joining the Global summit in Porto, reserve your seat now!The BioTech Pharma Summit 2017 will address issues around biosimilars science, global regulatory pathways, evidence for clinical applications, and education for prescribers and patients that are key to successful uptake of these products.
JOIN US FOR A SERIES OF KEYNOTES, PRESENTATIONS AND ROUNDTABLES
Learn best practices on the global R&D and regulatory landscape, designing biosimilar development programmes and bioan-alytics of biosimilars.
“The quality of attendees – as well as speakers – was the key differentiator for me.“ David Brindley, DPhil MEng FRSA | Senior Research Fellow Healthcare Translation
Who should attend
The BioTech Pharma Summit 2017 is an exclusive event designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions.
Chief Executives, Executive Directors, Vice Presidents, Heads and Team Leaders and Managers including:
▶ Biologics/Biotechnology/ Biogenerics
▶ Biopharmaceuticals
▶ Business Development
▶ Chief Scientific Officer
▶ Clinical Immunology
▶ Commercial Affairs
▶ Drug and Safety Assessment
▶ Drug Safety & Risk Management
▶ Health Economics
▶ Intellectual property
▶ Legal Affairs
▶ Legislation and Policy Advice
▶ Manufacturing
▶ Market Strategy
▶ Marketing & sales
▶ New Product Development
▶ Pharmacovigilance
▶ Preclinical and Clinical Development
▶ Pricing and Reimbursement
▶ Principal Scientist
▶ Process Control and Analytical
▶ Technologies
▶ Quality Affairs/ Quality Control
▶ Regulatory AffairsRegulatory Compliance
▶ R & D
From Industries Including
▶ Pharmaceutical and biotechnology
About EPM Group
EPM Group is a unique company that promotes global summits, conferences, B2B (business-to-business) meetings, seminars, workshops and develops collaborations between all enterprises in order to promote business development in all areas.New trends, Innovations, Modern technologies, New products, Emerging topics are generated for senior level executives to provide a cutting edge of business information and maximum return of investment for our clients from different areas, such as Pharmaceutical, Renewable Energy, Oil & Gas, Logistics and Supply Chain and Infrastructure.
Our goal is to become a top event company of designing, producing and delivering highly conceptual and fully integrated events.
Contact Details
Diogo Lino Ribeiro
Project Director, Europe | Porto Office
EM: diogo.ribeiro@epmgroup.org
PH: +351 915 239 640